Table 2.
Hazard ratios and 95% confidence intervals within 5 years of cancer diagnosis by health insurance status, New Jersey, 1999–2004, N = 54,002
| Health insurance status1 | |||
|---|---|---|---|
| Cancer type | Medicaid HR (95% CI) | Uninsured HR (95% CI) | Private referent |
| Breast (n = 17,939) | 1.56 (1.29–1.88) | 1.44 (1.22–1.69) | 1 |
| Cervical (n = 1832) | 1.32 (0.94–1.86) | 1.00 (0.75–1.34) | 1 |
| Colorectal (n = 7445) | 1.57 (1.28–1.93) | 1.41 (1.20–1.66) | 1 |
| Lung (n = 8185) | 1.21 (1.08–1.35) | 1.43 (1.31–1.57) | 1 |
| NHL2 (n = 3885) | 1.48 (1.04–2.10) | 1.69 (1.29–2.23) | 1 |
| Prostate (n = 11,842) | 2.98 (1.92–4.64) | 1.97 (1.41–2.77) | 1 |
| Bladder (n = 2874) | 1.37 (0.72–2.63) | 1.76 (1.14–2.71) | 1 |
1
Hazard ratios (HR) and 95% confidence intervals (95% CI) are from Cox proportional hazards regression models for cause-specific survival within 5 years of diagnosis as follows. Breast, cervical, prostate, and urinary bladder cancers adjusted for age, race/ethnicity, SES, marital status, and stage. Colorectal and lung cancers and non-Hodgkin lymphoma adjusted for the same variables plus sex.
2
Non-Hodgkin lymphoma.